Chemical Compound
(5'a,10a)-2'-Ethyl-9,10-dihydro-12'-hydroxy-5'-(phenylmethyl)ergotaman-3',6',18-trione; (6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; 9,10-Dihydroergostine; DE 145; Dihydroergostine; Dihydroergotamine Mesilate Imp. B
CAS Registry Number
3609-19-6
Primary record
(5'a,10a)-2'-Ethyl-9,10-dihydro-12'-hydroxy-5'-(phenylmethyl)ergotaman-3',6',18-trione; (6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; 9,10-Dihydroergostine; DE 145; Dihydroergostine; Dihydroergotamine Mesilate Imp. B
- 库存
- 8,220 克
- 纯度
- 98.3 %
- CAS
- 3609-19-6
化合物标识与属性
- CAS
- 3609-19-6
- PubChem CID
- 193378
- SMILES
- CC[C@@]1(C(=O)N2[C@H](C(=O)N3CCC[C@H]3[C@@]2(O1)O)CC4=CC=CC=C4)NC(=O)[C@@H]5C[C@H]6[C@@H](CC7=CNC8=CC=CC6=C78)N(C5)C
- Canonical SMILES
- CC[C@@]1(NC(=O)[C@@H]2C[C@@H]3c4cccc5[nH]cc(c45)C[C@H]3N(C)C2)O[C@@]2(O)[C@@H]3CCCN3C(=O)[C@H](Cc3ccccc3)N2C1=O
名称与同义词
- Dihydroergostin
- Dihydroergostine
- 9,10-Dihydroergostine
- RefChem:133807
- 3609-19-6
- AC1L4W55
- orb1697431
- SCHEMBL23115955
- DTXSID70957491
- DE-145
- C34H39N5O5
- KST-1A4686
- AR-1A6606
- CID193378
- AKOS040751576
- FD159573
- FT-0701195
- J1.029.749D
- (6aR,9R,10aR)-N-[(1S,2S,4R,7S)-7-benzyl-4-ethyl-2-hydroxy-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide
- Ergotaman-3',6',18-trione, 2'-ethyl-9,10-dihydro-12'-hydroxy-5'-(phenylmethyl)-, (5'alpha,10alpha)-
- (5'|A,10|A)-5'-benzyl-2'-ethyl-12'-hydroxy-3',6',18-trioxo-9,10-dihydroergotaman
- 40843-73-0
- (5'|A,10|A)-5'-Benzyl-2'-ethyl-12'-hydroxy-3',6',18-trioxo-9,10-dih ydroergotam
- 12'-hydroxy-5'-isobutyl-2'-isopropyl-9,10-dihydro-ergotamane-18,3',6'-trione
- Dihydroergocristine Mesilate EP Impurity G; Dihydroergotamine Mesilate EP Impurity B
- (2R,4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-4-ethyl-2-hydroxy-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.02,7.012,16]hexadeca-1(16),9,12,14-tetraene-4-carboxamide
- (5'a,10a)-2'-Ethyl-9,10-dihydro-12'-hydroxy-5'-(phenylmethyl)ergotaman-3',6',18-trione; (6aR,9R,10aR)-N-[(2R,5S,10aS,10bS)-5-benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide; 8H-Oxazolo[3,2-a]pyrrolo[2,1-c]pyrazine, ergotaman-3',6',18-trione deriv.; Indolo[4,3-fg]quinoline, ergotaman-3',6',18-trione deriv.; 9,10-Dihydroergostine; DE 145; Dihydroergostine; Dihydroergotamine Mesilate Imp. B
- (6aR,9R,10aR)-N-((2R,5S,10aS,10bS)-5-benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
- 9,10alpha-Dihydro-12 -hydroxy-2 -ethyl-5 alpha-benzylergotaman-3 ,6 ,18-trione
- N-(5-Benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-[1,3]oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-6-methylergoline-8-carboximidic acid
- N-[(2R,5S,10aS,10bS)-5-Benzyl-2-ethyl-10b-hydroxy-3,6-dioxooctahydro-8H-[1,3]oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl]-6-methylergoline-8beta-carboximidic acid